Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is hepatoblastoma (childhood liver cancer)?
Hepatoblastoma is the most common cancer of the liver in children, almost always occurring in babies and children under about 3 to 5 years of age. It develops from immature liver cells and usually shows up as a swelling or firm mass in the abdomen, sometimes found by a parent or on a routine check, occasionally with poor appetite, weight loss, or belly pain. A blood protein called alpha-fetoprotein (AFP) is elevated in most children with hepatoblastoma; it is very useful both for supporting the diagnosis and for tracking how the tumor responds to treatment and watching for any return. Hepatoblastoma is more common in children born very prematurely or with very low birth weight, and it is linked to a few inherited conditions — including Beckwith-Wiedemann syndrome and familial adenomatous polyposis (FAP) — so a diagnosis sometimes prompts genetic evaluation of the child and family. The encouraging reality is that hepatoblastoma is highly treatable, and most children are cured. The modern approach combines chemotherapy, which is very effective at shrinking these tumors, with surgery to remove the affected part of the liver. The liver's remarkable ability to regrow means a large portion can be removed safely, and the sequence often used — chemotherapy first to shrink the tumor, then an operation — turns many initially inoperable tumors into removable ones. For the most extensive tumors that involve too much of the liver to remove safely, a liver transplant offers a cure. Radiation therapy plays a smaller, selective role here; when it is used, doctors lean toward precise techniques such as proton therapy to spare the surrounding healthy organs in a young, growing body.
The main types
Doctors group hepatoblastoma (childhood liver cancer) by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Epithelial type | The tumor is made of liver-cell-like tissue; subtypes range from a favorable, very treatable form to less favorable patterns, which helps guide how intensive treatment should be. |
| Mixed epithelial-mesenchymal type | Contains both liver-cell-like and supporting (connective) tissue; still treated with the standard chemotherapy-and-surgery approach. |
| Small cell undifferentiated | An uncommon, more aggressive pattern (sometimes with low AFP and a specific gene change) that is treated more intensively. |
| Standard-risk / high-risk groupings | Children are sorted by how far the tumor has spread, AFP level, age, and other features into risk groups that set the intensity of chemotherapy and the surgical plan. |
Staging, in plain terms
Hepatoblastoma is not staged with the adult TNM system. Instead, doctors use a children's-cancer framework built around a system called PRETEXT (PRE-Treatment EXTent of disease). The liver is divided into four sections, and PRETEXT describes how many of those sections the tumor involves before any treatment — from PRETEXT I (one section, the most limited) to PRETEXT IV (all four sections). On top of that, additional letters flag features that make surgery harder or signal more advanced disease: involvement of the major liver veins or the large vein returning blood to the heart, growth into the main blood vessel that feeds the liver, tumor outside the liver, rupture, or spread to distant sites such as the lungs. These details are crucial because they determine the central plan: whether the tumor can be removed with part of the liver or whether a transplant will be needed, and how intensive the chemotherapy should be. Children are then grouped into risk categories using PRETEXT together with the AFP level, age, and whether the cancer has spread, and these risk groups guide the strength of treatment. Importantly, PRETEXT is often reassessed after the first rounds of chemotherapy (then called POST-TEXT) to decide the timing and type of surgery, because tumors frequently shrink enough to become removable. So the framework here is about anatomy and extent — how much liver is involved and what vital structures are nearby — paired with risk features, rather than a simple stage number.
| PRETEXT system — describes how many of the liver's four sections the tumor involves before treatment — combined with spread and risk features (not adult TNM) | What it generally means |
|---|---|
| PRETEXT I-II (limited) | Tumor confined to one or two sections of the liver; often removable with surgery after chemotherapy, with an excellent chance of cure. |
| PRETEXT III (more extensive) | Tumor involving three sections; usually shrunk with chemotherapy first, then removed if possible, with transplant considered if it remains unresectable. |
| PRETEXT IV (all sections) | Tumor involving all four sections of the liver; chemotherapy is given first, and a liver transplant is often the path to cure when removal of part of the liver isn't possible. |
| Metastatic (usually lungs) | Disease that has spread, most often to the lungs; treated with chemotherapy to clear the spread, then surgery to the liver (and sometimes the lung deposits), still with a meaningful chance of cure. |
The standard of care
Hepatoblastoma (Childhood Liver Cancer) is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Chemotherapy (cisplatin-based)
The backbone of treatment — effective drugs (built around cisplatin) shrink the tumor before surgery, often converting an inoperable tumor into a removable one, and clear any spread to the lungs.
Surgical resection
Removing the part of the liver containing the tumor; because the liver regrows, a large portion can be taken safely, and complete removal is central to cure.
Liver transplant
For tumors that involve too much of the liver to remove safely, replacing the liver offers a cure, with excellent results in experienced children's centers.
Risk-adapted therapy and AFP monitoring
Treatment intensity is matched to the child's risk group, and the AFP blood level is tracked to gauge response and watch for any return.
Selective radiation therapy
Used in specific situations — such as tumor left behind after surgery that can't be removed or treated otherwise — with precise techniques chosen to protect a growing child.
How radiation treatment works
Radiation therapy works by delivering focused energy that damages the DNA inside cancer cells so they can no longer grow and divide. In hepatoblastoma, radiation plays a deliberately small and selective role, and understanding why explains how it is used. The reason is that the two main tools — chemotherapy and surgery — are so effective. Cisplatin-based chemotherapy shrinks these tumors dramatically and clears spread to the lungs, while the liver's remarkable ability to regrow allows surgeons to remove a large portion of the organ; and for tumors too extensive to remove, a liver transplant can be curative. Together these cure most children without radiation. Radiation is therefore reserved for specific problems, such as tumor left behind after surgery that cannot be removed or controlled by other means, or, rarely, lung deposits that persist after chemotherapy and surgery. When radiation is used in a young child, protecting the developing body becomes a central concern, because growing tissues and organs are sensitive to radiation and there is a long lifetime ahead in which late effects could appear. This is where modern, highly precise techniques matter most: proton beam therapy deposits its dose in the tumor and then stops, sparing the nearby healthy liver, kidneys, bowel, and spine far better than older methods and reducing the radiation delivered to growing tissue. The goal in these selected cases is local control — eliminating a specific pocket of disease that surgery and chemotherapy could not — while keeping the dose to the rest of the body as low as possible. Because hepatoblastoma is so treatable with chemotherapy and surgery, decisions about radiation are made carefully by a children's cancer team, weighing the benefit of controlling residual disease against the importance of protecting a child's long-term health.
The main ways radiation is delivered for hepatoblastoma (childhood liver cancer):
Proton beam therapy
Proton beams deposit their dose precisely in the tumor and stop, sparing the surrounding liver, kidneys, bowel, and spine — especially valuable in young children to limit radiation to growing tissue and reduce long-term effects.
Selective adjuvant radiation
Focused radiation to residual disease that remains after surgery and cannot be removed or controlled by other means, used in carefully chosen cases as part of a coordinated plan.
Radiation for lung metastases (selected)
In rare situations, focused radiation can address lung deposits that persist after chemotherapy and surgery, complementing the main treatments.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Chemotherapy plus surgery cures most children: International childhood-liver-cancer trials show that cisplatin-based chemotherapy followed by surgery achieves high cure rates in hepatoblastoma, with chemotherapy often shrinking initially inoperable tumors enough to be removed.[1]
International hepatoblastoma cooperative-group trials
Liver transplant cures extensive tumors: For PRETEXT IV and other unresectable hepatoblastomas confined to the liver, liver transplantation after chemotherapy yields excellent long-term survival, making it a key option when partial liver removal isn't possible.[2]
Pediatric liver transplant for hepatoblastoma series
Proton therapy limits dose to growing tissue: When radiation is needed in children, proton beam therapy delivers a sharply targeted dose that spares surrounding organs and developing tissue, supporting its preference over conventional radiation to reduce long-term effects.[3]
Proton therapy in pediatric abdominal tumors
Common questions
Can hepatoblastoma be cured? Yes — most children with hepatoblastoma are cured. The combination of effective chemotherapy to shrink the tumor and surgery to remove the affected part of the liver works very well, and the liver's ability to regrow makes large operations possible. Even extensive tumors confined to the liver can be cured with a liver transplant, and disease that has spread to the lungs can often still be cured with chemotherapy and surgery.
Will my child need radiation? Usually not. Most children are cured with chemotherapy and surgery alone, so radiation is reserved for specific situations, such as tumor left behind after surgery that can't be removed. When radiation is used in a young child, doctors favor very precise techniques like proton therapy to protect the surrounding organs and growing tissue and to limit long-term effects.
Why is the AFP blood test important? Alpha-fetoprotein (AFP) is a protein that is high in most children with hepatoblastoma. It helps support the diagnosis at the start, and because the level falls as the tumor responds to treatment, doctors use it to track how well therapy is working and to watch for any sign the cancer is coming back after treatment ends.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.